Accelerate Diagnostics Stock Forecast - Naive Prediction

AXDX Stock  USD 1.01  0.05  5.21%   
The Naive Prediction forecasted value of Accelerate Diagnostics on the next trading day is expected to be 1.41 with a mean absolute deviation of  0.22  and the sum of the absolute errors of 13.43. Accelerate Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Accelerate Diagnostics stock prices and determine the direction of Accelerate Diagnostics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Accelerate Diagnostics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Accelerate Diagnostics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Accelerate Diagnostics' systematic risk associated with finding meaningful patterns of Accelerate Diagnostics fundamentals over time.
Check out Historical Fundamental Analysis of Accelerate Diagnostics to cross-verify your projections.
For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.
  
Inventory Turnover is likely to drop to 1.62 in 2024. Payables Turnover is likely to drop to 1.88 in 2024. Common Stock Shares Outstanding is likely to rise to about 7.5 M in 2024, whereas Net Loss is likely to drop (59.1 M) in 2024.

Open Interest Against 2024-04-19 Accelerate Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Accelerate Diagnostics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Accelerate Diagnostics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Accelerate Diagnostics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Accelerate Diagnostics' open interest, investors have to compare it to Accelerate Diagnostics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Accelerate Diagnostics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Accelerate. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Accelerate Diagnostics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Accelerate Diagnostics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Accelerate Diagnostics' price structures and extracts relationships that further increase the generated results' accuracy.
A naive forecasting model for Accelerate Diagnostics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Accelerate Diagnostics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Accelerate Diagnostics Naive Prediction Price Forecast For the 29th of March

Given 90 days horizon, the Naive Prediction forecasted value of Accelerate Diagnostics on the next trading day is expected to be 1.41 with a mean absolute deviation of 0.22, mean absolute percentage error of 0.09, and the sum of the absolute errors of 13.43.
Please note that although there have been many attempts to predict Accelerate Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Accelerate Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Accelerate Diagnostics Stock Forecast Pattern

Backtest Accelerate DiagnosticsAccelerate Diagnostics Price PredictionBuy or Sell Advice 

Accelerate Diagnostics Forecasted Value

In the context of forecasting Accelerate Diagnostics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Accelerate Diagnostics' downside and upside margins for the forecasting period are 0.01 and 9.14, respectively. We have considered Accelerate Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.01
1.41
Expected Value
9.14
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Accelerate Diagnostics stock data series using in forecasting. Note that when a statistical model is used to represent Accelerate Diagnostics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria117.536
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2166
MAPEMean absolute percentage error0.1481
SAESum of the absolute errors13.4297
This model is not at all useful as a medium-long range forecasting tool of Accelerate Diagnostics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Accelerate Diagnostics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Accelerate Diagnostics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Accelerate Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.168.89
Details
Intrinsic
Valuation
LowRealHigh
0.153.0010.73
Details
2 Analysts
Consensus
LowTargetHigh
8.199.009.99
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Accelerate Diagnostics. Your research has to be compared to or analyzed against Accelerate Diagnostics' peers to derive any actionable benefits. When done correctly, Accelerate Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Accelerate Diagnostics.

Other Forecasting Options for Accelerate Diagnostics

For every potential investor in Accelerate, whether a beginner or expert, Accelerate Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Accelerate Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Accelerate. Basic forecasting techniques help filter out the noise by identifying Accelerate Diagnostics' price trends.

Accelerate Diagnostics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accelerate Diagnostics stock to make a market-neutral strategy. Peer analysis of Accelerate Diagnostics could also be used in its relative valuation, which is a method of valuing Accelerate Diagnostics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Accelerate Diagnostics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Accelerate Diagnostics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Accelerate Diagnostics' current price.

Accelerate Diagnostics Market Strength Events

Market strength indicators help investors to evaluate how Accelerate Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Accelerate Diagnostics shares will generate the highest return on investment. By undertsting and applying Accelerate Diagnostics stock market strength indicators, traders can identify Accelerate Diagnostics entry and exit signals to maximize returns.

Accelerate Diagnostics Risk Indicators

The analysis of Accelerate Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Accelerate Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting accelerate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Accelerate Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Accelerate Diagnostics' short interest history, or implied volatility extrapolated from Accelerate Diagnostics options trading.

Pair Trading with Accelerate Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Accelerate Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelerate Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Accelerate Stock

  0.76MBRX Moleculin Biotech Upward RallyPairCorr
  0.69MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Accelerate Stock

  0.83DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.79MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.67MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.66EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Accelerate Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Accelerate Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Accelerate Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Accelerate Diagnostics to buy it.
The correlation of Accelerate Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Accelerate Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Accelerate Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Accelerate Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Accelerate Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Accelerate Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Accelerate Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Accelerate Diagnostics Stock:
Check out Historical Fundamental Analysis of Accelerate Diagnostics to cross-verify your projections.
For more information on how to buy Accelerate Stock please use our How to Invest in Accelerate Diagnostics guide.
Note that the Accelerate Diagnostics information on this page should be used as a complementary analysis to other Accelerate Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Accelerate Stock analysis

When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Accelerate Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accelerate Diagnostics. If investors know Accelerate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accelerate Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.52)
Revenue Per Share
1.065
Quarterly Revenue Growth
0.115
Return On Assets
(0.62)
The market value of Accelerate Diagnostics is measured differently than its book value, which is the value of Accelerate that is recorded on the company's balance sheet. Investors also form their own opinion of Accelerate Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Accelerate Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accelerate Diagnostics' market value can be influenced by many factors that don't directly affect Accelerate Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accelerate Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Accelerate Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accelerate Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.